Brief: Maxcyte Inc Will Consolidate Two Lines Of Common Stock
21/11/2018 08:34
Nov 21 (Reuters) - MaxCyte Inc MXCT.L :
* MAXCYTE INC - CONSOLIDATION OF TWO LINES OF COMMON STOCK
INTO A
SINGLE UNRESTRICTED LINE OF COMMON STOCK (MXCT.L)
* MAXCYTE - TRANSFER OF ALL STOCK COMPRISING REGULATION S
RESTRICTED TRADING LINE MXCR.L TO UNRESTRICTED COMMON STOCK
(MXCT.L) TRADING LINE
Source text for Eikon: ID:nRSU9686Ha
Further company coverage: MXCT.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte, Inc. MaxCyte, Inc. - MXCR - Second Price Monitoring Extn
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Price Monitoring Extension
Brief: Maxcyte And Allogene Therapeutics Sign Clinical And Commercial License Agreement To Enable The Advancement Of Allogeneic Car T (Allocar T™) Therapies
Brief: Maxcyte Signs Agreement With KSQ Therapeutics
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Agreement with KSQ Therapeutics